Novel Promoters Derived from Chinese Hamster Ovary Cells via In Silico and In Vitro Analysis-Reference-Cited by-同舟云学术

Novel Promoters Derived from Chinese Hamster Ovary Cells via In Silico and In Vitro Analysis

Published:2019-08-09 Issue:11 Volume:14 Page:1900125
ISSN:1860-6768
Container-title:Biotechnology Journal
language:en
Short-container-title:Biotechnol. J.

Author:

Nguyen Ly N.¹²^ORCID,Baumann Martina²,Dhiman Heena¹²,Marx Nicolas¹²,Schmieder Valerie¹²,Hussein Mohamed¹²,Eisenhut Peter¹²,Hernandez Inmaculada²,Koehn Jadranka³,Borth Nicole¹²

Affiliation:

1. Department of BiotechnologyBOKU University of Natural Resources and Life SciencesMuthgasse 18 1190 Vienna Austria

2. Austrian Center of Industrial Biotechnology GmbH1190 Vienna Austria

3. Rentschler Biopharma 88471 Laupheim Germany

Publisher

Wiley

Subject

Molecular Medicine,Applied Microbiology and Biotechnology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/biot.201900125

Reference46 articles.

1. CHO cells in biotechnology for production of recombinant proteins: current state and further potential

2. The choice of mammalian cell host and possibilities for glycosylation engineering

3. P.Zhang K. F.Chan R.Haryadi M.Bardor Z.Song inFuture Trends in Biotechnology(Ed: J.‐J. Zhong) Springer Berlin2013 pp.63–87.

4. Advances in Mammalian Cell Line Development Technologies for Recombinant Protein Production

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Manipulating gene expression levels in mammalian cell factories: An outline of synthetic molecular toolboxes to achieve multiplexed control;New Biotechnology;2024-03

2. Enhancing productivity of Chinese hamster ovary (CHO) cells: synergistic strategies combining low-temperature culture and mTORC1 signaling engineering;Frontiers in Bioengineering and Biotechnology;2023-11-21

3. Mitigating transcriptional bottleneck using a constitutively active transcription factor, VP16-CREB, in mammalian cells;Metabolic Engineering;2023-11

4. LncRNA analysis of mAb producing CHO clones reveals marker and engineering potential;Metabolic Engineering;2023-07

5. Glutamine synthetase (GS) knockout (KO) using CRISPR/Cpf1 diversely enhances selection efficiency of CHO cells expressing therapeutic antibodies;Scientific Reports;2023-06-28